MAP2K7 and esophageal squamous cell carcinoma: ERK inhibition by PD98059 (MEK inhibitor) and Akt inhibition by LY294002 (PI3K inhibitor) in ESCC TE-10 cells, in which PTK7 expression increases invasion via MMP-9 secretion, decreased MMP-9 secretion [15].